SCHEMBL4013931

SCHEMBL4013931

Cc1ccc2c(N3CCN(C(=O)O)CC3)nc(Cl)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 2/20 0.50
▸ AKT1 P31749 2/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ RAD52 P43351 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ GBA1 P04062 3/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CFTR P13569 1/20 0.39
▸ DHODH Q02127 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4013403 0.85 GBA1 (0.51) HRH4AKT1SMN1; SMN2MEN1KMT2A
SCHEMBL1623325 0.81 AKT1 (0.48) HRH4AKT1SMN1; SMN2ALDH1A1MAPT
SCHEMBL1623322 0.81 AKT1 (0.48) HRH4AKT1SMN1; SMN2ALDH1A1MAPT
SCHEMBL4016152 0.81 HRH4 (0.44) HRH4ALDH1A1RAD52
SCHEMBL5503906 0.79 HRH4 (0.51) HRH4SMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3718191 0.79 SMN1; SMN2 (0.62) HRH4SMN1; SMN2MEN1KMT2AL3MBTL1
Hydrochloric Acid SCHEMBL4020304 0.78 HRH4 (0.50) HRH4SMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL22631353 0.78 ABL1 (0.45) SMN1; SMN2ALDH1A1
SCHEMBL5503125 0.77 HRH4 (0.52) HRH4SMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL183884 0.77 PRKDC (0.47) HRH4AKT1ALDH1A1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784393-B1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2009-07-01 — — EP disclosed
WO-2006028904-A9 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2006-06-22 — — WO disclosed
Send feedback